|
Re: Mark Day Panelist at RESI 2017 Early Stage Therapeutics Panel
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 27, 2017 04:01PM
|
|
Renal trial delayed (again)
|
6
|
Resverlogix Corp.
|
Sep 27, 2017 10:19PM
|
|
Re: Renal trial delayed (again)
|
4
|
Resverlogix Corp.
|
Sep 28, 2017 05:24AM
|
|
Re: FDA Late approval of Betomace and what changed their mind?
|
3
|
Resverlogix Corp.
|
Sep 28, 2017 05:32PM
|
|
Re: FDA Late approval of Betomace and what changed their mind?
|
1
|
Resverlogix Corp.
|
Sep 28, 2017 06:33PM
|
|
BETonMACE ClinicalTrial.gov updated
|
3
|
Resverlogix Corp.
|
Sep 29, 2017 06:46AM
|
|
Re: BETonMACE ClinicalTrial.gov updated
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 09:50AM
|
|
The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 12:14PM
|
|
Re: The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 01:14PM
|
|
Re: The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
3
|
Resverlogix Corp.
|
Sep 29, 2017 03:32PM
|
|
Re: The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
3
|
Resverlogix Corp.
|
Sep 29, 2017 03:55PM
|
|
Re: BETonMACE ClinicalTrial.gov updated
|
|
Resverlogix Corp.
|
Sep 29, 2017 08:07PM
|
|
Re: Renal trial delayed (again)
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 08:27PM
|
|
Re: Renal trial delayed (again)
|
1
|
Resverlogix Corp.
|
Sep 30, 2017 11:30AM
|
|
Re: Renal trial delayed (again)
|
4
|
Resverlogix Corp.
|
Sep 30, 2017 12:35PM
|
|
Re: Renal trial delayed (again)
|
7
|
Resverlogix Corp.
|
Sep 30, 2017 02:30PM
|
|
BIO Investor Forum
|
2
|
Resverlogix Corp.
|
Oct 01, 2017 07:58AM
|
|
BIO Investor Forum
|
1
|
Zenith Epigenetics
|
Oct 01, 2017 08:01AM
|
|
Re: BIO Investor Forum
|
2
|
Resverlogix Corp.
|
Oct 01, 2017 01:53PM
|
|
Re: FA
|
3
|
Resverlogix Corp.
|
Oct 02, 2017 03:56PM
|
